LloydsPharmacy Clinical Homecare, a leading provider of home healthcare services in the UK, on Monday announced the appointment of Paul Adams as the
company's new Chief Executive Officer (CEO).
Before assuming his role at LPCH at the end of last year, Adams was leading transformation efforts at DD Group, formerly known as Dental Directory.
With a career spanning over two decades, Adams has held influential positions at Diageo, Smith+Nephew, and served as a CEO for various Private Equity companies.
He has also co-authored "The Little Black Book of Change."
Adams will lead the LPCH's mission to pioneer the delivery of specialist clinical treatment therapies to patients, thereby enhancing patient outcomes within
homecare and community settings while improving accessibility.
"Barcodes are becoming obsolete, so we needed a unique selling point," comments Business Development Manager at Huxley Europe, Richard Wertheimer,
celebrating the relaunch of its HuxQ10 capsules.
Now boasting a rare triple certification, HuxQ10 capsules are Halal approved by Halal Trust, Kosher approval by Rabbi Adler, and certification as vegan.
This milestone marks a significant step for the company, making HuxQ10 accessible to a wider audience.
Coenzyme Q10, or Q10, is a naturally occurring vitamin-like substance in the body, playing a crucial role in mitochondrial biogenetics and ATP production, which
is vital for cellular energy.
It also acts as a powerful antioxidant, capable of regenerating alpha-tocopherol, the active form of vitamin E.
